Eden vs Fridays (2026): prices, structure, verdict

On tirzepatide, Fridays is cheaper: $359 versus $408 a month all-in — a $49 monthly gap, $588 across a year of maintenance dosing, and Fridays's figure is dose-flat while Eden's structure is not.

Updated 2026-08-10 · figures captured 2026-08-09 · how we verify

On semaglutide, Fridays is cheaper: $175 versus $198 a month all-in — a $23 monthly gap, $276 across a year of maintenance dosing.

§ Side by side

§ Each record, read aloud

The two records, condensed

Eden: the record, condensed

Eden’s tirzepatide program bills $408 a month once every mandatory fee is counted, measured at the 10 mg maintenance basis. Pricing steps with the dose here: from $348 at entry to $408 at the 10 mg basis. Multiply the wrong one of those by twelve and your budget is off by $720 a year, which is why every ranking on this site uses the larger number.

The all-in figure already contains a compulsory $99 monthly membership. That is the honest way to quote it: a bundled price is only misleading when its parts are advertised separately, and here the medication-only $309 would be exactly that kind of mirage.

Context for that figure: it ranks #16 of 17 in the verified tirzepatide index — $193/month above the floor (NexLife↗, $215) — and sits $41 under the brand benchmark (Zepbound (LillyDirect↗), $449 at maintenance). Annualized, a monthly-billed year here runs $4,896.

Start with the load-bearing figure: $198 a month, all-in, is what Eden charges for semaglutide at the 2.4 mg basis. Because pricing is flat across the ladder (0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg), a dose increase at Eden is a clinical event and not a billing one. Whatever your prescriber decides, the invoice does not move, which makes this one of the few programs whose headline figure you can actually plan a year around.

Inside that $198 sits a mandatory $99-a-month membership. We fold it in automatically — the medication-only figure the marketing may lead with is $99, and it is not a price anyone can actually pay, because the membership cannot be declined.

To place the number: #10 of 20 verified programs, with the floor $65/month below at Oak Longevity ($133); the approved-product yardstick (Wegovy (NovoCare↗)) sits at $349, so the compounded case here is worth $151 a month. A year at this figure: $2,376 monthly-billed.

Operationally at Eden: shipping included; commitment membership auto-renews; cancellation membership auto-renews until cancelled; pharmacy not publicly named — ask in writing before paying; states: most states; evidence source-verified, captured 2026-08-05. The full record with source and archive links: the Eden page · visit Eden ↗

Fridays: the record, condensed

Start with the load-bearing figure: $359 a month, all-in, is what Fridays charges for tirzepatide at the 10 mg basis. It is a flat structure: 2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available) all bill identically. In a market where most low advertised prices quietly belong to the starter dose, a flat figure is the difference between a quote and a teaser.

The absence worth noticing: no mandatory membership. Across this index memberships run $25–$145 a month and hide outside headline prices; here the headline is the bill.

Context for that figure: it ranks #13 of 17 in the verified tirzepatide index — $144/month above the floor (NexLife, $215) — and sits $90 under the brand benchmark (Zepbound (LillyDirect), $449 at maintenance). Annualized, a monthly-billed year here runs $4,308.

Start with the load-bearing figure: $175 a month, all-in, is what Fridays charges for semaglutide at the 2.4 mg basis. It is a flat structure: 0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg all bill identically. In a market where most low advertised prices quietly belong to the starter dose, a flat figure is the difference between a quote and a teaser.

The absence worth noticing: no mandatory membership. Across this index memberships run $25–$145 a month and hide outside headline prices; here the headline is the bill.

To place the number: #7 of 20 verified programs, with the floor $42/month below at Oak Longevity ($133); the approved-product yardstick (Wegovy (NovoCare)) sits at $349, so the compounded case here is worth $174 a month. A year at this figure: $2,100 monthly-billed.

Operationally at Fridays: shipping included; commitment annual plan for lowest rate; cancellation not published; pharmacy not publicly named — ask in writing before paying; states: not published; evidence third-party reported, captured 2026-08-05. The full record with source and archive links: the Fridays page · visit Fridays ↗

Tirzepatide: the duel in full

The tirzepatide arithmetic between these two is short: $359 (Fridays) against $408 (Eden). $49 a month sounds survivable; $588 a year is a decision.

Structure sharpens the gap: Fridays’s figure is dose-flat (2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available) all bill the same), while Eden’s is not — so Fridays’s number is a ceiling and Eden’s advertised entry ($348) is a floor. Comparing a ceiling to a floor flatters the floor; this site compares maintenance to maintenance, which is the table above.

Eden’s total includes a mandatory $99/month membership; Fridays has none. The all-in figures above neutralize that difference — but the membership side has an exit consideration the other lacks: a fee that recurs until you affirmatively cancel it.

Semaglutide: the duel in full

Put the two semaglutide figures side by side and hold them there: Fridays at $175, Eden at $198 — a $23 monthly spread that compounds to $276 over a maintenance year and $552 over two.

Both figures are dose-flat, which is the cleanest possible comparison: two ceilings, no titration surprises on either side, and the $23 gap is exactly what it appears to be.

Eden’s total includes a mandatory $99/month membership; Fridays has none. The all-in figures above neutralize that difference — but the membership side has an exit consideration the other lacks: a fee that recurs until you affirmatively cancel it.

Translate the $49/month spread into medication: $588 a year equals roughly 1.6 months of therapy at the cheaper program’s rate. That is the honest unit for gaps in this market — months of treatment, not abstract dollars — and it is why small-looking monthly differences decide long courses.

On best published rate — the lower of each program’s month-to-month price and its labeled 12-month-plan rate, which is the sort most price roundups quietly run — the duel reads: Eden $408/mo month-to-month versus Fridays $359/mo month-to-month. Same winner on both bases — Fridays leads whether you compare month-to-month prices or committed-plan rates, which makes this one of the cleaner verdicts in the index. Prepaid rates are upfront commitments with refund terms to verify before they count.

§ The clock, run forward

Three, six, twelve, twenty-four months — best path each way

3 months: Eden $1,224 monthly; Fridays $1,077 monthly — best path favors Fridays by $147. 6 months: Eden $2,448 monthly; Fridays $2,154 monthly — best path favors Fridays by $294. 12 months: Eden $4,896 monthly; Fridays $4,308 monthly — best path favors Fridays by $588. 24 months: Eden $9,792 monthly; Fridays $8,616 monthly — best path favors Fridays by $1,176.

Prepaid paths above are billed upfront and assume the published rate holds (the 24-month figures extend the 12-month rate, an assumption worth naming). The honest reading: over short horizons the monthly gap decides; over long horizons the prepaid ladders and structural traps (dose tiers, memberships) take over — which is exactly the split the verdict section below scores.

The same clock, on semaglutide

3 mo: Eden $594 vs Fridays $525 — $69 to Fridays. 6 mo: Eden $1,188 vs Fridays $1,050 — $138 to Fridays. 12 mo: Eden $2,376 vs Fridays $2,100 — $276 to Fridays. 24 mo: Eden $4,752 vs Fridays $4,200 — $552 to Fridays.

Same rules as above: prepaid figures are upfront commitments, and the 24-month lines extend the 12-month rate as a stated assumption. Where the two molecules crown different winners between these two programs, that split is itself the finding — molecule choice and provider choice are separate decisions.

§ Structure vs structure

Everything besides the price

Coverage: Eden publishes “most states”; Fridays publishes “not published” — for anything short of an explicit 50-state claim, intake is the final word.

Neither names its pharmacy publicly — the single most useful disclosure in this category, missing on both sides; ask each, in writing, before paying either.

Exit terms: Eden — membership auto-renews; membership auto-renews until cancelled. Fridays — annual plan for lowest rate; not published.

Evidence: Eden source-verified (captured 2026-08-05); Fridays third-party reported (2026-08-05).

A rule that has held across this index: disclosure predicts disclosure. Whichever of these two publishes more — pharmacies, states, exit terms — is usually the one whose invoice matches its ad.

In the full tirzepatide index these two sit at #16 and #13 of 17: between them lie 2 other programs, and the whole ladder is at cheapest tirzepatide providers. In the full semaglutide index these two sit at #10 and #7 of 20: between them lie 2 other programs, and the whole ladder is at cheapest semaglutide providers.

§ If you move

Switching between Eden and Fridays

Prescriptions do not transfer like phone numbers: moving in either direction means completing the destination’s intake and having its prescriber write a new patient-specific prescription. The mechanics that prevent a bad month: confirm the destination serves your state and quotes your current dose in writing before cancelling anything; time the first new shipment to overlap the last old one rather than gap it; cancel the origin per its published terms (Eden: membership auto-renews until cancelled; Fridays: not published) and screenshot the confirmation; and never leave a prepaid balance stranded — which is the standing argument for prepaying only after a program has already earned a few monthly cycles.

§ Verdict by situation

Which one, for whom

§ More pairings